Skip to content

Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models

Diagnosing Pulmonary Embolism in Pregnancy: Are Biomarkers and Clinical Prediction Models Useful?

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02709174
Enrollment
59
Registered
2016-03-15
Start date
2014-02-28
Completion date
2015-08-31
Last updated
2024-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism

Keywords

Pulmonary Embolism, Pregnancy, D-Dimer

Brief summary

Objective: To evaluate whether trimester specific d-dimer levels and brain natriuretic protein (BNP), along with the modified Wells score (MWS), is a useful risk stratification tool to exclude pregnant women at low-risk of pulmonary embolism (PE) from diagnostic imaging with radiation exposure.

Detailed description

To account for all women meeting the study eligibility criteria, this study utilized a combined prospective and retrospective arm. Pregnant women who underwent diagnostic imaging to evaluate for suspected PE at our institution were prospectively enrolled from February 2014 to August 2015. Both d-dimer and BNP serum levels were drawn, and a MWS was assigned. All pregnant women diagnosed with a PE that underwent diagnostic imaging and had a d-dimer level drawn from January 2009 to June 2014 were retrospectively enrolled. Patient electronic records were used to apply the MWS and analyze their risk.

Interventions

PROCEDUREblood draw

blood draw

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* adult pregnant women \>= 18 years old * d-dimer obtained and if the patient was pregnant at the time of PE diagnosis * patient presented to the Emergency Department or Labor and Delivery unit * patient presented with signs and symptoms suspicious for PE

Exclusion criteria

* non-pregnant patients * patients \< 18 years old

Design outcomes

Primary

MeasureTime frameDescription
Serum D-dimer levels (ug/ml)18 monthsTrimester specific D-dimer levels to identify pregnant women at low risk for pulmonary embolism, thereby avoiding radiation exposure

Secondary

MeasureTime frameDescription
Modified Well's Criteria- a risk scoring system for likelihood of pulmonary embolism18 monthsA Modified Wells score of \>4 suggests pulmonary embolism is likely and therefore diagnostic imaging needed

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026